Langerhans cells are more efficiently transduced than dermal dendritic cells by adenovirus vectors expressing either group C or group B fibre protein: implications for mucosal vaccines.

作者: George Rozis , Shamika de Silva , Adel Benlahrech , Timos Papagatsias , Julian Harris

DOI: 10.1002/EJI.200425939

关键词:

摘要: Vaccines against viruses need to target dendritic cells (DC) and stimulate mucosal immunity. Most vaccine studies have focussed on monocyte-derived or dermal DC (dDC) but recent evidence suggests that Langerhans (LC) may immunity more effectively. New chimeric adenovirus vectors expressing fibre protein from group B adenoviruses (rAd5/11), which utilise CD46 rather than the Coxsackie receptor (CAR), been developed as vaccines improve transduction overcome problems of pre-existing vector Transduction LC dDC by rAd5/11 standard rAd5 green fluorescent (GFP) showed both types were efficiently transduced rAd5. Although expression integrins αvβ3 αvβ5, recognise penton base mediate virus internalisation, was similar in dDC, expressed higher levels GFP. electroporation plasmid also resulted GFP LC, suggesting differences between two populations at a post-entry stage. with either did not induce maturation affect their ability T cells. These findings suggest strategies be worthy exploration.

参考文章(28)
Allan B. Dietz, Stanimir Vuk-Pavlovic, High efficiency adenovirus-mediated gene transfer to human dendritic cells. Blood. ,vol. 91, pp. 392- 398 ,(1998) , 10.1182/BLOOD.V91.2.392.392_392_398
Delphine Rea, Menzo J. E. Havenga, Maayke van den Assem, Roger P. M. Sutmuller, Angelique Lemckert, Rob C. Hoeben, Abraham Bout, Cornelis J. M. Melief, Rienk Offringa, Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. Journal of Immunology. ,vol. 166, pp. 5236- 5244 ,(2001) , 10.4049/JIMMUNOL.166.8.5236
Brenda Faiola, Herman F. Staats, Eli Gilboa, Angel Porgador, Thomas J. Palker, Intranasal Immunization with CTL Epitope Peptides from HIV-1 or Ovalbumin and the Mucosal Adjuvant Cholera Toxin Induces Peptide-Specific CTLs and Protection Against Tumor Development in Vivo Journal of Immunology. ,vol. 158, pp. 834- 841 ,(1997)
Herman F. Staats, Curtis P. Bradney, William M. Gwinn, Shawn S. Jackson, Gregory D. Sempowski, Hua-Xin Liao, Norman L. Letvin, Barton F. Haynes, Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization. Journal of Immunology. ,vol. 167, pp. 5386- 5394 ,(2001) , 10.4049/JIMMUNOL.167.9.5386
Andrea Tuettenberg, Helmut Jonuleit, Thomas Tüting, Jürgen Brück, Volker Biermann, Stefan Kochanek, Jürgen Knop, Alexander H. Enk, Early Adenoviral Gene Expression Mediates Immunosuppression by Transduced Dendritic Cell (DC): Implications for Immunotherapy Using Genetically Modified DC Journal of Immunology. ,vol. 172, pp. 1524- 1530 ,(2004) , 10.4049/JIMMUNOL.172.3.1524
Jacques Banchereau, Ralph M. Steinman, Dendritic cells and the control of immunity Nature. ,vol. 392, pp. 245- 252 ,(1998) , 10.1038/32588
Alexander V Pereboev, Jill M Nagle, Mikhail A Shakhmatov, Pierre L Triozzi, Qiana L Matthews, Yosuke Kawakami, David T Curiel, Jerry L Blackwell, Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule. Molecular Therapy. ,vol. 9, pp. 712- 720 ,(2004) , 10.1016/J.YMTHE.2004.02.006
I. M. Belyakov, M. A. Derby, J. D. Ahlers, B. L. Kelsall, P. Earl, B. Moss, W. Strober, J. A. Berzofsky, Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge Proceedings of the National Academy of Sciences of the United States of America. ,vol. 95, pp. 1709- 1714 ,(1998) , 10.1073/PNAS.95.4.1709
Hartmut Stecher, Dmitry M. Shayakhmetov, George Stamatoyannopoulos, André Lieber, A capsid-modified adenovirus vector devoid of all viral genes: assessment of transduction and toxicity in human hematopoietic cells Molecular Therapy. ,vol. 4, pp. 36- 44 ,(2001) , 10.1006/MTHE.2000.0410
Anuj Gaggar, Dmitry M Shayakhmetov, André Lieber, CD46 is a cellular receptor for group B adenoviruses Nature Medicine. ,vol. 9, pp. 1408- 1412 ,(2003) , 10.1038/NM952